CureSearch Community Impact Award – Clinical Trials (CCIA-CT) is co-funded by Gateway for Cancer Research to award clinical trial researchers who are focusing on pilot or early phase (Phase Zero, I or II) clinical trial programs for pediatric cancers.

The thirteen CureSearch Community Impact Awards – Clinical Trials award recipients are:

Pietro Bonacossa
A Phase II Study of Intraventricular Methotrexate
Variety Children's Hospital dba Miami Children's Hospital
Miami, FL

Kathleen Dorris
Novel System for Solid Tumor Measurements in Pediatric Oncology Trials
The Children's Hospital Association
Aurora CO

Jennifer Elster
Cancer Germline Antigen (CGA) Vaccine for Relapsed Brain Tumors
University of Louisville Research Foundation, Inc.
Louisville, KY

Adam Green
A Early Phase Trial of Systemic Chemotherapy Penetration into DIPG Tumors
Regents of the University of Colorado, a body corporate, for and on behalf of the University of Colorado Denver
Aurora, CO

Leo Mascarenhas
Early Phase Clinical Trial Expansion
Children's Hospital, Los Angeles
Los Angeles, CA

Gary Mason
Infrastructure for Pediatric Clinical Cancer Trials at Children's Hospital
Children's Hospital of Pittsburgh of UPMC
Pittsburgh, PA

William Petersen
Randomized Controlled Trial of Genistein in Pediatric Cancer
The Rector and Visitors of the University of Virginia
Charlottesville, VA

Bassem Razzouk
Peyton Manning Children's Hospital at St.Vincent Clinic Trials Application
St. Vincent Hospital and Health Care Center, Inc.
Indianapolis, IN

David Walterhouse
Lurie Children’s Clinical Trial Program
Ann & Robert H. Lurie Children's Hospital of Chicago
Chicago, IL

Zhihong Wang
Support for CRAs who are involved in conducting clinical trials
Wayne State University
Detroit, MI

Brenda Weigel
Supplemental Support for Uof MN Phase I/II Clinical Trial Program
Regents of the University of Minnesota - Twin Cities
Minneapolis, MN

Cynthia Wetmore
Lead Coordinator for Optimizing the Developmental Therapeutics Program
Children's Healthcare of Atlanta, Inc.
Atlanta, GA

Sarah Whittle
Pilot Study of High Risk Neuroblastoma Induction Chemotherapy Without GCSF
Baylor College of Medicine
Houston, TX